1) Welcome to our #accredited #tweetorial on optimal mgt of #hyperkalemia in the patient with #CKD. Earn 0.5h #CME/CE credit by following this thread. I am Sourabh Sharma MD DNB FASN 🇮🇳 @iamnephrologist & u have found the ONLY source for CE credit delivered entirely on Twitter!
2) This program is supported by educational grants from AstraZeneca, Bayer, & Chiesi & is intended for #healthcare providers. See faculty disclosures https://cardiometabolic-ce.com/disclosures/. Educational credit for #physicians #physicianassociate #nurses #nursepractitioners #pharmacists 🇺🇸🇨🇦🇪🇺🇬🇧
3) Potassium first isolated by Humphry Davy in 1807 by electrolysis (Coined word from “Potash” [Dutch]). The periodic table symbol K was derived from kali (alkali) [Arabic].
https://en.wikipedia.org/wiki/Potassium
#NephroNotes #NephPearls #FOAMed #MedEd @MedTweetorials #CardioTwitter
4) Re potassium #homeostasis: 98% of the body's K lies in intracellular space➡️ helping determine resting membrane potential & intracellular electronegativity.
10% of K secretion is via the colon (↑significantly in advancing CKD) 🔓https://kidney360.asnjournals.org/content/1/1/65 #NephroNotes
5) There is debate abt the definition of hyperK (>5? >5.5?), but it is classified by serum K & ECG. Mortality risk is independent of symptoms, but not ECG findings, as bradycardia/junctional rhythm/QRS widening→Poor outcome.
🔓https://www.kidney-international.org/article/S0085-2538(19)31012-9/fulltext
🔓
6) Arrhythmia in Hyperkalemia
Moderate HyperK: Fast Na channel activation; ↑excitability/conduction velocity: Peaked T
Severe HyperK: Fast Na channel inactivation/Inwardly rectifying K channel activation: Wide QRS/Conduction block
🔓
7) There are multiple causes of #hyperkalemia:
a. Pseudohyperkalemia
b. Redistribution
c. Excess intake
d. Impaired renal K secretion
In #CKD, relative risk of hyperK approximately doubles for every⬇️in eGFR of 15 mL/min
🔓https://www.ccjm.org/content/84/12/934
#NephroNotes #NephPearls #MedEd
8) Because it may be unexpected, we must be especially cautious of drug-induced hyperkalemia
🔓https://academic.oup.com/ndt/article/34/Supplement_3/iii2/5652181
#NephroNotes #NephPearls #FOAMed #MedEd
9) So let's focus on #hyperkalemia in #CKD ➡️adverse outcomes, as it restricts RAASi & MRA usage. #CKD patients have multiple risk factors for hyperkalemia. For those on dialysis, long interdialytic gap ↑hyperkalemia chances
https://www.nature.com/articles/nrneph.2014.168
#NephroNotes #NephPearls
10) This table is a nice summary of causes and treatment of hyperkalemia across continuum of kidney function, from 🔓https://cjasn.asnjournals.org/content/13/1/155
#NephroNotes #NephPearls #FOAMed #MedEd
11) A low-K diet is generally recommended in advanced #CKD, but @goKDIGO suggests interventional trials to determine optimal recommendations, as there is no direct evidence to link dietary K & serum K, and the benefits of K can’t be ignored
🔓https://kidney360.asnjournals.org/content/1/1/65
#NephroNotes
12) Guidelines for use of #RAAS inhibitors are intertwined with K homeostasis. Strive for maximum tolerated RAASi therapy! Treat hyperkalemia & reinitiate RAASi after resolution, then reassess K level within 1 wk
🔓https://www.ccjm.org/content/84/12/934
🔓https://www.mayoclinicproceedings.org/article/S0025-6196(20)30618-2/fulltext
#NephPearls
13) Patient education is🔑:
@nkf recommends⬆️patient awareness of hyperK
👉Educational tools
👉Lifestyle change
👉Dietary modification
👉Campaigns
👉Involve allied healthcare professionals
Hyperkalemia is often asymptomatic; regular K monitoring needed!🔓
14) The National Institute for Health and Care Excellence #NICE offers a systematic Treatment Approach to #hyperkalemia
👉Account for clinical priorities
👉↓variability
👉↑patient outcome
👉↓adverse events
🔓https://ukkidney.org/sites/renal.org/files/RENAL%20ASSOCIATION%20HYPERKALAEMIA%20GUIDELINE%202020.pdf
#NephroNotes #NephPearls #FOAMed #MedEd
15) So when hyperK happens, how is it treated? Acutely:
👉IV calcium ↓cardiac membrane excitation (1-3 min)
👉Insulin/glucose & β agonist redistribute K to ICS (30-60 min) but not ↓total body K
👉β Agonists: short duration of effect (2-4hrs)
👉Sodium bicarbonate ↑K elimination
16) #Hemodialysis increases total K elimination & is used for resistant acute hyperkalemia
🔓https://www.mayoclinicproceedings.org/article/S0025-6196(20)30618-2/fulltext
#NephroNotes #NephPearls #FOAMed #MedEd
17) So among acute treatment options, different medications have rapid, intermediate or delayed onset of action
Rapidly & intermediately acting medications are required in acute hyperkalemia management
🔓https://pubmed.ncbi.nlm.nih.gov/23882341/
#NephroNotes #NephPearls #FOAMed #MedEd
18) So let's look at drug administration & safety of different emergency use medications
IV Calcium preparation
👉Calcium Chloride
👉Calcium Gluconate
🔓https://ukkidney.org/sites/renal.org/files/RENAL%20ASSOCIATION%20HYPERKALAEMIA%20GUIDELINE%202020.pdf
#NephroNotes #NephPearls
19) Insulin/Glucose Infusion: Consider
👉Drug administration & safety
👉Alternative glucose preparations
🔓https://ukkidney.org/sites/renal.org/files/RENAL%20ASSOCIATION%20HYPERKALAEMIA%20GUIDELINE%202020.pdf
#NephroNotes #NephPearls #FOAMed #MedEd
20) #Salbutamol: Drug administration & safety
Effective but more likely to produce side effects
🔓https://ukkidney.org/sites/renal.org/files/RENAL%20ASSOCIATION%20HYPERKALAEMIA%20GUIDELINE%202020.pdf
#NephroNotes #NephPearls #FOAMed #MedEd
21) So now let's look at oral potassium binders, which are more useful in chronic mgt & can help facilitate #RAASi optimization. Which of the following binders has the most rapid onset of action after oral administration?
22) Mark your best response & return TOMORROW for the correct answer and the remainder of this program! đź‘Źto @sibgokcay @dr_nikhilshah @kdjhaveri @proychaudhuryMD @divyaa24 @arvindcanchi @priti899 @vjha126 @NephPrasad @Gawad_Nephro @SmeetaSinha @Priyasinghbmc @Joe_Vassalotti
23) Welcome back! I am @iamnephrologist and we're talking about #hyperkalemia in #CKD and what to do about it! You are earning🆓CE/#CME, #physicians #physicianassistants #nursepractitioners #pharmacists #nurses. Shout-outs to @vipvargh @gudnephron @SwastiThinks @docanjuyadav
24) We were about to start talking about the oral K binders. (BTW earn MORE CE/#CME on this topic at https://cardiometabolic-ce.com/category/hyperkalemia/) Yes, prune juice is a K binder, but it's not quick, and it may make a bigger mess than Na polystyrene sulfonate. So the correct answer was D.
25) So these oral potassium binders are to be considered in chronic #hyperkalemia despite diuretic therapy/corrected metabolic acidosis. They potentially allow continuation/optimization of RAASi/ MRA
🔓https://www.mayoclinicproceedings.org/article/S0025-6196(17)30309-9/fulltext
#NephroNotes #NephPearls #FOAMed #MedEd
26) So in the K binder🌎, there is old and there is new.
New binders have opened new horizons for treatment & prevention of hyperkalemia
🔓https://ukkidney.org/sites/renal.org/files/RENAL%20ASSOCIATION%20HYPERKALAEMIA%20GUIDELINE%202020.pdf
#NephroNotes #NephPearls #FOAMed #MedEd
27) Start w/the old. Sodium/Calcium Polysterene Sulfonate clinical studies:
👉Limited evidence for effectiveness/safety
👉With sorbitol, can cause colonic necrosis
👉Nonselective for K, with affinity for Ca/Mg ions
👉Caution: Na & volume overload
🔓
28) And then the new. First, #patiromer sorbitex calcium clinical studies:
👉Efficacy established in randomized, placebo-controlled, phase 2 and 3 trials (CKD/ HF/RAASi)
👉Onset of action~ 7 hours
👉No serious AEs
🔓https://www.frontiersin.org/articles/10.3389/fmed.2021.653634
#NephPearls #FOAMed #MedEd
29) Sodium Zirconium Cyclosilicate (#SZC) clinical studies:
👉Efficacy & safety established in Ph 2 & 3 trials (#CKD/#HF/#DM/#RAASi)
👉assoc'd w/ ↑Bicarbonate
👉High selectivity for K & ammonium ions
👉fast onset, starts in small bowel
👉No serious AEs
🔓
30) Summary: Clinical trials of oral potassium binders
🔓https://ukkidney.org/sites/renal.org/files/RENAL%20ASSOCIATION%20HYPERKALAEMIA%20GUIDELINE%202020.pdf
#NephroNotes #NephPearls #FOAMed #MedEd
31) Treatment of #Hyperkalemia in #hemodialysis patients:
👉Hyperkalaemia contributes to mortality in HD (3-5% deaths)
👉K ⤴️is most common immediately post 3-day weekend break
👉Adjust dialysate K as per 🔓
32) In summary, the treatment of hyperkalemia is likely to evolve in the coming years with the availability of novel drugs & the development of new strategies to improve safety. Clinical decisions on when to treat & how aggressively to treat require a pt-centered approach …
33) … guided by the clinical setting and rate of change in serum K+ level. Patients with moderate levels of hyperkalemia pose the greatest dilemma, especially when acuity is low, but warrant intervention to avoid deterioration.
34) Severe hyperkalemia risks arrhythmias & cardiac arrest, therefore prompt recognition and intervention is required. How big a problem is it? In-hospital mortality is significantly higher in patients w/ hyperkalaemia (X%) hypokalaemia (Y%) vs normokalaemia (Z%). What are X,Y,Z?
35) Per NICE guidelines, the correct answer is B, more exactly hyperkalemia (18.1%) compared to those with hypokalemia (5.0%) or normokalemia (3.9%). Pts with severe hyperK (> 6.5 mmol/l) are most at risk & in one report (🔓https://pubmed.ncbi.nlm.nih.gov/23171442/), hospital mortality was 30.7%.
36) And that's it! You made it! Go grab your CE/#CME certificate at https://cardiometabolic-ce.com/hyperk5/. I am @iamnephrologist and I hope you'll FOLLOW @cardiomet_CE AND @ckd_ce for more #accredited #tweetorials from expert authors all over the 🌎🌍🌏!
Originally tweeted by cardio-met (@cardiomet_CE) on April 20, 2022.